Ardent Health, Inc.
ARDT
$9.23
$0.020.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.43B | 6.32B | 6.33B | 6.20B | 6.02B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.43B | 6.32B | 6.33B | 6.20B | 6.02B |
| Cost of Revenue | 2.66B | 2.66B | 2.66B | 2.62B | 2.57B |
| Gross Profit | 3.77B | 3.67B | 3.67B | 3.58B | 3.45B |
| SG&A Expenses | 2.58B | 2.54B | 2.50B | 2.44B | 2.40B |
| Depreciation & Amortization | 162.49M | 155.70M | 152.52M | 150.14M | 147.14M |
| Other Operating Expenses | 681.69M | 647.31M | 634.55M | 553.53M | 505.15M |
| Total Operating Expenses | 6.09B | 6.00B | 5.95B | 5.77B | 5.63B |
| Operating Income | 339.41M | 325.58M | 378.40M | 432.32M | 397.03M |
| Income Before Tax | 286.75M | 286.36M | 361.23M | 420.50M | 380.69M |
| Income Tax Expenses | 57.09M | 56.22M | 64.47M | 78.94M | 67.87M |
| Earnings from Continuing Operations | 229.66 | 230.14 | 296.76 | 341.56 | 312.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -95.38M | -94.32M | -91.71M | -86.70M | -88.14M |
| Net Income | 134.28M | 135.81M | 205.06M | 254.86M | 224.68M |
| EBIT | 339.41M | 325.58M | 378.40M | 432.32M | 397.03M |
| EBITDA | 501.89M | 481.29M | 530.92M | 582.46M | 544.17M |
| EPS Basic | 0.95 | 0.97 | 1.46 | 1.82 | 1.64 |
| Normalized Basic EPS | 0.63 | 0.54 | 0.78 | 1.06 | 0.90 |
| EPS Diluted | 0.95 | 0.96 | 1.45 | 1.81 | 1.63 |
| Normalized Diluted EPS | 0.62 | 0.53 | 0.78 | 1.05 | 0.89 |
| Average Basic Shares Outstanding | 564.23M | 563.02M | 561.71M | 557.59M | 543.33M |
| Average Diluted Shares Outstanding | 566.62M | 565.55M | 564.28M | 560.59M | 545.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |